z-logo
open-access-imgOpen Access
The effect of low‐level laser therapy on diabetic foot ulcers: A meta‐analysis of randomised controlled trials
Author(s) -
Huang Jing,
Chen Jiangqiong,
Xiong Shuyuan,
Huang Jingui,
Liu Zhiping
Publication year - 2021
Publication title -
international wound journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 63
eISSN - 1742-481X
pISSN - 1742-4801
DOI - 10.1111/iwj.13577
Subject(s) - medicine , meta analysis , diabetic foot , confidence interval , low level laser therapy , randomized controlled trial , relative risk , web of science , diabetic foot ulcer , strictly standardized mean difference , medline , laser therapy , diabetes mellitus , laser , physics , political science , law , optics , endocrinology
Our purpose was to perform a meta‐analysis to evaluate the effect of Low‐level laser therapy (LLLT) on diabetic foot ulcers (DFUs). The PubMed, Cochrane, Embase, Web of Science, Chinese BioMedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), VIP and Wanfang databases were searched systematically up to August 27, 2020. Studies that met the inclusion criteria were included in the analysis. A total of 13 randomised controlled trials (RCTs) and 413 patients were analysed. Compared with the control group, LLLT significantly increased the complete healing rate (risk ratio [RR] = 2.10, 95% confidence interval [CI] 1.56‐2.83, P  < .00001), reduced the ulcer area (standardised mean difference [SMD] = 3.52, 95% CI 1.65‐5.38, P  = .0002), and shortened the mean healing time (SMD = −1.40, 95% CI −1.90 to −0.91, P  < .00001) of patients with DFUs. The quality of the evidence was very low according to the GRADE system. LLLT is a promising and effective adjuvant treatment to accelerate the healing of DFUs. Further evidence from larger samples and higher quality RCTs is needed to prove the effect of LLLT and to determine the most appropriate parameters for the healing of DFUs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here